Thieler Law Corp advises investors with losses exceeding $100,000 of the May 18, 2015 lead plaintiff deadline in a class action lawsuit filed against Omnicell Inc (NASDAQ: OMCL) (“Omnicell” or “the Company”). The suit is pending in the U.S. District Court for the Northern District of California and investors, who purchased Omnicell securities between May 2, 2014 and March 2, 2015, have until May 18, 2015 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Omnicell securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 866-6157 or emailing mail@thielerlaw.com. No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that a "side letter" arrangement existed with a Company customer for certain discounts and Company products that were provided at no cost, but which were not reflected in final invoices paid by the customer, that Omnicell Inc lacked adequate internal controls over financial reporting, and additionally that as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

If you were negatively impacted by your investment in Omnicell securities between May 2, 2014 and March 2, 2015and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185